Covered recipient · General Payments record
AMY R ECKSTEIN VANGELDER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2023
$955.50
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $322.51 | 13 |
| Gift | $118.80 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MannKind Corporation | $136.24 | 3 |
| Horizon Pharma plc | $97.33 | 2 |
| DEXCOM, INC. | $38.75 | 2 |
| Lilly USA, LLC | $37.21 | 2 |
| ABBVIE INC. | $34.66 | 1 |
| Abbott Laboratories | $23.61 | 1 |
| SANOFI-AVENTIS U.S. LLC | $22.50 | 1 |
| Amgen Inc. | $19.07 | 1 |
| Novo Nordisk AS | $16.99 | 1 |
| Amneal Pharmaceuticals LLC | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.61 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018961267 | CMS |
| ABBVIE INC. | $34.66 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003871011 | CMS |
| Amgen Inc. | $19.07 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020230123 | CMS |
| Amneal Pharmaceuticals LLC | $14.95 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053559015 | CMS |
| Dexcom, Inc. | $23.63 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054864991 | CMS |
| Dexcom, Inc. | $15.12 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054864997 | CMS |
| Horizon Therapeutics plc | $44.44 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987099449 | CMS |
| Horizon Therapeutics plc | $52.89 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987099451 | CMS |
| Lilly USA, LLC | $17.20 | 02/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032699095 | CMS |
| Lilly USA, LLC | $20.01 | 06/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032671131 | CMS |
| MannKind Corporation | $17.44 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056330435 | CMS |
| MannKind Corporation | $59.40 | 09/07/2023 | Gift | Undisputed | 01/23/2026 | 1056330445 | CMS |
| MannKind Corporation | $59.40 | 12/14/2023 | Gift | Undisputed | 01/23/2026 | 1056330453 | CMS |
| Novo Nordisk Inc | $16.99 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001566203 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.50 | 05/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049917925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.